台股 » 個股 » 英濟 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

英濟

(3294)
可現股當沖
  • 股價
    24.80
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    820
  • 產業
    上櫃 電子零組件類股
  • 102人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
英濟 (3294)籌碼相關-元大-崇德 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/1005/2406/0806/2207/0607/2208/0208/1608/3009/1409/2810/1210/2611/0811/2212/0612/2001/0401/1802/0802/2403/0803/1803/2804/1004/2004/22202530354045May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

元大-崇德 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/11223.1000.0024.0027,2780.03%
2025/04/0800.00224.9524.95-27,615-0.03%
2025/04/0200.00130.5530.75-17,647-0.01%
2025/03/31231.2000.0030.1027,7300.03%
2025/03/27134.6500.0033.7017,7380.01%
2025/03/2600.000.435.2535.15-0.47,7250.00%
2025/03/25135.8000.0035.8017,7120.01%
2025/03/21237.50137.4537.0017,6850.01%
2025/03/19538.2200.0038.2557,6430.07%
2025/03/18138.80138.3038.0507,6200.00%
2025/03/14336.2800.0036.5037,5570.04%
2025/03/130.136.4000.0036.250.17,5490.00%
2025/03/12136.70136.8036.6007,5310.00%
2025/03/10136.35136.1536.2007,4900.00%
2025/03/07136.3000.0036.3017,4760.01%
2025/03/05138.20138.0038.1007,4400.00%
2025/03/04537.6200.0037.8057,4210.07%
2025/03/03436.95537.0837.00-17,389-0.01%
2025/02/27539.43338.6038.1527,3550.03%
2025/02/26739.63739.5839.1507,2950.00%
2025/02/251.138.21138.7538.800.17,1770.00%
2025/02/2410.138.62339.2239.007.17,1370.10%
2025/02/21339.58438.6338.45-17,081-0.01%
2025/02/20341.13340.6740.3506,9960.00%
2025/02/191140.91341.1340.8586,9400.12%
2025/02/181442.401342.3641.5016,8600.01%
2025/02/1700.00740.5841.05-76,518-0.11%
2025/02/141941.701041.7040.6096,4550.14%
2025/02/133440.863640.3541.00-26,159-0.03%
2025/02/121941.1725.141.5340.45-6.16,040-0.10%
2025/02/114.138.79738.6738.30-2.95,713-0.05%
2025/02/10541.50340.6740.3025,6250.04%
2025/02/073241.143940.7340.20-75,401-0.13%
2025/02/062840.021340.5040.95155,1040.29%
2025/02/052.237.4000.0037.252.24,9510.04%
2025/02/04236.23137.8037.5514,9010.02%
2025/01/223240.363739.6039.20-54,767-0.10%
2025/01/206141.026141.1440.7004,2900.00%
2025/01/1711140.9710240.6440.1093,7400.24% 大買/大賣/
2025/01/16937.671138.8839.40-22,834-0.07%
2025/01/151635.521834.9335.85-22,632-0.08%
2025/01/141033.77333.6033.7072,4510.29%
2025/01/131135.031034.9733.2012,3590.04%
2025/01/101035.99635.6335.0042,2010.18%
2025/01/09837.581138.3436.40-32,043-0.15%
2025/01/085.235.43335.7335.652.21,7140.13%
2025/01/075636.773737.0436.00191,5671.21%
2025/01/06536.012335.1936.50-181,059-1.70%
2025/01/03133.70234.3333.20-1973-0.10%
2025/01/021133.261033.6632.5019010.11%
2024/12/31532.99232.3533.7538180.37%
2024/12/3000.00131.2530.70-1657-0.15%
2024/12/27830.80830.2530.0006210.00%
2024/12/25530.00529.9830.3506010.00%
2024/12/2400.00530.2530.25-5538-0.93%
2024/12/17126.9500.0026.8015440.18%
2024/12/13127.6000.0027.3515740.17%
2024/12/12128.5000.0028.4515920.17%
2024/11/2500.00129.8029.85-11,350-0.07%
2024/11/1500.00128.5528.50-11,394-0.07%
2024/11/05128.8000.0029.5011,4870.07%
2024/11/0400.00129.8529.00-11,528-0.07%
2024/10/29130.3000.0030.2011,5540.06%
2024/10/28130.7500.0030.8011,5600.06%
2024/10/25131.5000.0031.5011,5870.06%
2024/10/2300.00432.6032.40-41,661-0.24%
2024/10/2200.00531.8032.10-51,684-0.30%
2024/10/2100.00531.5031.75-51,726-0.29%
2024/10/16131.2000.0031.0012,3500.04%
2024/10/14131.6500.0031.4012,7190.04%
2024/10/11231.8300.0031.6522,7260.07%
2024/10/08133.30433.1033.20-32,745-0.11%
2024/10/04230.8800.0031.9022,7270.07%
2024/09/27132.1000.0031.8512,7590.04%
2024/09/26433.09431.7031.7002,7620.00%
2024/09/20132.7000.0032.1512,7660.04%
2024/09/1900.00232.2532.70-22,767-0.07%
2024/09/13132.9000.0033.4512,7680.04%
2024/09/1200.00434.2033.10-42,781-0.14%
2024/09/1000.00134.3533.85-12,777-0.04%
2024/09/09232.65333.7733.45-12,698-0.04%
2024/09/0500.00133.1032.85-12,647-0.04%
2024/09/04231.03131.0030.9012,6180.04%
2024/09/024.534.1100.0033.904.52,6070.17%
2024/08/30233.85634.1633.55-42,524-0.16%
2024/08/29431.8800.0031.4042,3970.17%
2024/08/28532.73733.2732.00-22,426-0.08%
2024/08/27130.7000.0030.9512,3530.04%
2024/08/21131.4500.0031.3012,5300.04%
2024/08/20131.40132.2032.2002,5390.00%
2024/08/1900.00132.0031.40-12,565-0.04%
2024/08/1300.00130.3030.00-12,847-0.04%
2024/08/1200.00230.3530.05-22,848-0.07%
2024/08/0900.00129.9029.60-12,857-0.03%
2024/08/0700.00129.5029.55-12,861-0.03%
2024/08/06126.50126.6026.9002,8770.00%
2024/08/05628.4000.0028.4062,8650.21%
2024/08/02531.8800.0031.5552,8600.17%
2024/07/291031.82231.3031.2082,9130.27%
2024/07/26233.88134.0034.0012,8870.03%
2024/07/23936.17136.1035.8082,8760.28%
2024/07/22737.41136.9536.5562,8690.21%
2024/07/19340.20440.5938.95-12,847-0.04%
2024/07/18441.35142.0041.1032,8140.11%
2024/07/178.542.671843.0743.70-9.52,681-0.35%
2024/07/16440.0315.241.5241.80-11.22,348-0.48%
2024/07/15638.08437.6038.0022,1980.09%
2024/07/11236.9800.0036.6022,2050.09%
2024/07/0300.00336.6535.85-33,425-0.09%
2024/07/02134.80135.1034.8003,5920.00%
2024/07/01135.25135.6535.1503,6290.00%
2024/06/28135.6000.0035.6013,7150.03%
2024/06/27235.4500.0035.2523,7890.05%
2024/06/24135.8000.0035.8014,1360.02%
2024/06/2000.00337.0536.95-34,627-0.06%
2024/06/19336.62437.6536.45-14,768-0.02%
2024/06/18937.65237.2537.5074,7830.15%
2024/06/12135.0000.0035.5515,4660.02%
2024/06/11435.4400.0035.3045,5750.07%
2024/06/0700.00536.3536.80-55,701-0.09%
2024/06/06536.25235.6036.0535,8230.05%
2024/06/0500.00138.0036.95-15,983-0.02%
2024/06/03439.361539.5639.00-116,481-0.17%
2024/05/30138.45138.6037.3006,4480.00%
2024/05/291239.02139.1538.95116,4750.17%
2024/05/2700.00136.8037.35-16,395-0.02%
2024/05/24235.9500.0036.4526,3800.03%
2024/05/2100.00336.8038.00-36,374-0.05%
2024/05/202.240.0100.0037.602.26,3560.03%
2024/05/16334.7500.0035.0536,1990.05%
2024/05/15235.3500.0034.8026,2400.03%
2024/05/13835.0000.0034.8086,5030.12%
2024/05/08137.45137.2537.1006,7490.00%
2024/05/06137.4500.0037.3516,7480.01%
2024/04/2600.00336.6235.30-36,717-0.04%
2024/04/2500.00136.1536.10-16,684-0.01%
2024/04/2300.00135.6035.55-16,601-0.02%
〈焦點股〉益得攜英濟開發複方吸入劑 逆勢攻上漲停Anue鉅亨-2023/04/25
英濟拿下益得複方吸入劑給藥設備訂單 生醫事業添動能Anue鉅亨-2023/04/24
英濟 相關文章